Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
CORONA

Corona Remedies Share Price

 

 

Corona Remedies live price: ₹1779. It opened at ₹1,779 vs previous close ₹1,782; intraday high/low: ₹1,830/₹1,767. The 50 DMA stands at ₹1,645.70.

Corona Remedies Performance

  • Today's Low
  • ₹1,767
  • Today's High
  • ₹1,830
  • 52 Week Low
  • ₹1,337
  • 52 Week High
  • ₹1,949
  • Open Price₹1,779
  • Previous Close₹1,782
  • Volume12,231
  • 50 DMA₹1,645.70
  • 100 DMA₹1,561.48
  • 200 DMA-

Corona Remedies Chart

Investment Returns

  • Over 1 Month + 9.85%
  • Over 3 Month + 13.41%
  • Over 6 Month + 67.51%
  • Over 1 Year + 67.51%

Smart Investing Starts Here Start SIP with Corona Remedies for Steady Growth!

Invest Now

Corona Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 58.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 10,880
  • P/B Ratio
  • 15.5
  • Average True Range
  • 89.7
  • EPS
  • 32.67
  • Dividend Yield
  • 0
  • MACD Signal
  • 40.37
  • RSI
  • 58.91
  • MFI
  • 50.42

Corona Remedies Financials

Corona Remedies Technicals

EMA & SMA

Current Price
₹1,779.00
-2.8 (-0.16%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹1,716.16
  • 50 Day
  • ₹1,645.70
  • 100 Day
  • ₹1,561.48
  • 200 Day
  • -

Resistance and Support

1807.27 Pivot Speed
  • R3 1,926.53
  • R2 1,895.27
  • R1 1,838.53
  • S1 1,750.53
  • S2 1,719.27
  • S3 1,662.53

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Corona Remedies Limited is a fast-growing Indian pharmaceutical company focused on women’s healthcare, cardio-diabeto, pain management, and urology. It operates two manufacturing facilities in Gujarat and Himachal Pradesh with 11 production lines and EU-GMP/WHO-GMP certifications.

Corona Remedies Ltd has an operating revenue of Rs. 1,403.18 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 17% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 17% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 21 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Corona Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-11 Audited Results & Final Dividend
2026-02-02 Quarterly Results
2026-01-02 Quarterly Results Inter-alia, to consider and approve the financial results for the period ended September 30, 2025 per share(100%)Final Dividend
Date Purpose Remarks
2026-06-19 FINAL Rs.10.00 per share(100%)Final Dividend
View Corona Remedies Dividend History Arrow

Corona Remedies Shareholding Pattern

69%
6.35%
0.58%
2.25%
0%
0.77%
21.05%

Corona Remedies FAQs

Corona Remedies share price is ₹1,779 As on 20 May, 2026 | 10:25

The Market Cap of Corona Remedies is ₹10880.4 Cr As on 20 May, 2026 | 10:25

The P/E ratio of Corona Remedies is 58.8 As on 20 May, 2026 | 10:25

The PB ratio of Corona Remedies is 15.5 As on 20 May, 2026 | 10:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23